Susquehanna International Group’s Mustang Bio MBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-47
Closed -$58K 13581
2021
Q4
$58K Buy
47
+29
+161% +$46.8K ﹤0.01% 12468
2021
Q3
$36K Sell
18
-44
-71% -$94.5K ﹤0.01% 12447
2021
Q2
$155K Sell
62
-62
-50% -$152K ﹤0.01% 11828
2021
Q1
$308K Sell
124
-102
-45% -$303K ﹤0.01% 10537
2020
Q4
$642K Buy
226
+13
+6% +$31.1K ﹤0.01% 7741
2020
Q3
$503K Buy
213
+135
+173% +$333K ﹤0.01% 7667
2020
Q2
$186K Buy
78
+39
+100% +$91.2K ﹤0.01% 9101
2020
Q1
$77K Sell
39
-11
-22% -$28.2K ﹤0.01% 9474
2019
Q4
$152K Buy
50
+19
+61% +$43.5K ﹤0.01% 8938
2019
Q3
$76K Sell
31
-18
-37% -$49.2K ﹤0.01% 9665
2019
Q2
$136K Buy
+49
New +$140K ﹤0.01% 9439

Other funds holding MBIO

Susquehanna International Group's MBIO Position: Q4 2024 in Review

Susquehanna International Group sold out of Mustang Bio (MBIO) in Q4 2024, closing a stake of 1,326 shares — an estimated $15.6K sold.

Susquehanna International Group first reported a position in MBIO in Q1 2018 and held it in 18 quarters. The position peaked at $863K in Q1 2018. 30 funds tracked by Wall St. Rank hold MBIO as of Q4 2024.

  • Susquehanna International Group reported no remaining Mustang Bio position as of Q4 2024 after selling out during the quarter.
  • Susquehanna International Group sold 1,326 Mustang Bio shares in Q4 2024, an estimated $15.6K.
  • Susquehanna International Group first reported a position in Mustang Bio in Q1 2018 and held it in 18 quarters.
  • Susquehanna International Group's Mustang Bio position peaked at $863K in Q1 2018.
  • 30 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.